Study shows VR is twice as effective as morphine at treating pain

By Callum Rivett
Virtual reality could soon be making an impact in healthcare, as a study by the Human Interface Technology Lab's SnowWorld has shown that VR can divert...

Virtual reality could soon be making an impact in healthcare, as a study by the Human Interface Technology Lab's SnowWorld has shown that VR can divert a patient's attention away from their pain and into the computerised world.

Opioid usage is fast becoming an epidemic in the United States, with prescriptions trebling in the past three decades. In 2015, the US Centres for Disease Control and Prevention estimated that over 16,000 people died from a prescription drug overdose. The proposed alternative is therapy by virtual reality. 

The experimental therapy has been devised by psychologist Hunter Hoffman, who trialled his idea on army veterans and burn victims and discovered that patients reported a 50% reduction in pain whilst they were playing his VR game - a simple distraction involving throwing snowballs at penguins.

That success has led HITLab to create Firsthand Technology, a company dedicated to creating new technologies to help ease chronic pain and suffering. 

Virtual and augmented reality has actually been used as far back as the 1960s when US Air Force veteran turned inventor Tom Furness tried to treat phobias and teach foreign language using the technology. Furness founded the HIT Lab in 1989 and earned the lifetime achievement award for his work in VR and AR.

A second version of the virtual reality game is already in testing and early signs suggest it's going well - all but one of 40 people in a clinical trial reported reduced pain. Most reported a drop in pain levels of 60-75%, whereas morphine only averages around a 30% reduction. 

The hypothesis has caught on and is being tested by similar laboratories in North America, and all have reported an improvement in patients following VR simulations.

Share

Featured Articles

Fighting the Great Resignation with predictive analytics

As employers grapple with challenges brought about by the Great Resignation, could predictive analytics be the key to solving these problems?

Executive Q&A with Dr. Shu Wei Goh, COO, Skymind

Dr. Shu Wei Goh is also co-founder of the global AI ecosystem builder and VC firm, Skymind. He joins Technology Magazine for a chat about his journey

Biotech giant Benchling launch Alphafold AI from DeepMind

The Alphafold beta feature on the Benchling platform integrates deep learning into biomolecule design, boosting scientists in the biotech industry

Preparing for quantum: next steps for enterprise

Enterprise IT

How to strategise as a Chief Technology Officer

Digital Transformation

Tech leaders say AI reads human emotions better than people

AI & Machine Learning